Life Sciences Alternative Funding Panel

Join us at the New Jersey Bioscience Center for insights into alternative sources of funding to advance life sciences companies in New Jersey.

This panel discussion will focus on securing funding from non-traditional sources, and will address the following questions:

• How will the next generation of drugs, diagnostics, and devices be funded?
• What new models are there that might change the paradigm?
• Is there a better way to fund early and emerging commercial biomedical research?

Panelists Include:

• Josh Barer, Managing Director at Hibiscus BioVentures
• Judith Sheft, Executive Director, NJ CSIT
• Jorge Ramirez, Vice President, M&A and Business Development, Quest Diagnostics

Moderated by John Pennett, Partner, Life Sciences and Technology Group, Eisner Advisory Group LLC